Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ISRCTN25916618) titled 'HMR code: 25-018' on June 29.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Phase I trial in healthy participants
Primary Sponsor: Silence Therapeutics (United Kingdom)
Condition:
Healthy volunteers
Other
Intervention:
This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.
Recruitment Status: Not Recruiting
Phase: Phase I
Date of First Enrollment: 01/07/2026
Ta...